-
1 week ago | 
pulmonologyadvisor.com | Colby Stong
In vivo platelet activation and related pathways may be associated with small airways disease and pulmonary vascular changes in smokers with and without chronic obstructive pulmonary disease (COPD), according to study findings published in Respiratory Medicine.
-
1 week ago | 
thecardiologyadvisor.com | Colby Stong
Minimally invasive surgery is associated with reduced in-hospital mortality after intracerebral hemorrhage (ICH), researchers reported in Stroke. The retrospective cohort study analyzed data from the American Heart Association Get With The Guidelines (GWTG)-Stroke Registry in the United States between January 2011 and December 2021. All participants were diagnosed with a nontraumatic ICH. The exposure was minimally invasive surgery and the primary outcome was in-hospital mortality.
-
1 week ago | 
gastroenterologyadvisor.com | Colby Stong
The global incidence of adverse events during colonoscopy is low, however, risks such as perforation and bleeding still occur at consistent rates, according to a study in the American Journal of Gastroenterology. Researchers conducted a systematic review and meta-analysis to evaluate the global incidence of adverse events (AEs) associated with colonoscopy. A literature search was performed in PubMed, Embase, and Cochrane Library databases in February 2024, with an updated search in December 2024.
-
1 week ago | 
gastroenterologyadvisor.com | Colby Stong
Relatively high rates of bronchiectasis were found in an analysis of chest computed tomography (CT) scans of patients with inflammatory bowel diseases (IBD), researchers reported in Chest. The retrospective cohort study evaluated the prevalence, risk factors, and clinical characteristics of IBD-related bronchiectasis (IBD-BE) in patients with IBD from a large tertiary medical center in Israel between January 2022 and January 2023.
-
1 week ago | 
dermatologyadvisor.com | Colby Stong
Rilzabrutinib may be effective for patients with H1-antihistamine–refractory chronic spontaneous urticaria (CSU), according to the results of a study published in JAMA Dermatology.
-
1 week ago | 
thecardiologyadvisor.com | Colby Stong
The number of US adults who were exclusively smoking cigarettes decreased by 6.8 million from 2017 to 2023, although it was offset by about a 7.2-million-person increase in the number who were exclusively using e-cigarettes (ie, vaping), according to study findings published in the Morbidity and Mortality Weekly Report.
-
1 week ago | 
pulmonologyadvisor.com | Colby Stong
The combination of antifibrotic and pulmonary vasodilator therapy may improve transplant-free survival in patients with pulmonary hypertension (PH) associated with pulmonary fibrosis, researchers reported in Therapeutic Advances in Respiratory Disease. Researchers at Temple University in Philadelphia assessed the effect of pulmonary vasodilator/antifibrotic therapy on transplant-free survival and 6-minute walk distance (6MWD) in patients with PH-pulmonary fibrosis.
-
1 week ago | 
thecardiologyadvisor.com | Colby Stong
The offspring of mothers who smoked during pregnancy have increased blood pressure (BP) and a higher risk for hypertension in early adolescence compared with nonexposed offspring, according to results of a study in the Journal of the American Heart Association. Researchers reviewed data from the Longitudinal Study of Australian Children (LSAC) and the Child Health CheckPoint study. The LSAC’s birth cohort enrolled offspring aged 0 to 1 year, with biennial data collection since 2004.
-
2 weeks ago | 
pulmonologyadvisor.com | Colby Stong
Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, with the highest effectiveness evident against severe forms of COVID-19, researchers reported in BMJ Open Respiratory Research. Researchers evaluated the extent to which having a SARS-CoV-2 infection during the pre-Omicron or Omicron era of the pandemic conferred future protection against reinfection, taking into account a wide range of symptoms and severities.
-
2 weeks ago | 
dermatologyadvisor.com | Colby Stong
Lymphovascular invasion (LVI) is an independent risk factor for predicting adverse outcomes in patients with cutaneous squamous cell carcinoma (CSCC), according to study results published in the Journal of the American Academy of Dermatology. To assess outcomes associated with LVI in this patient population, a retrospective study was conducted among 12 centers with CSCC databases, of which 10 centers were in the United States, 1 in Spain, and 1 in Brazil.
